World's Best Scientists 2026 revealed!
Friedrich Grimminger

Friedrich Grimminger

D-Index & Metrics

Medicine

D-Index
119
Citations
55378
World Ranking
3879
National Ranking
213

Overview

Friedrich Grimminger is affiliated with the University of Giessen in Germany. Their research spans fields primarily within Medicine, with significant contributions to Biochemistry, Genetics, and Molecular Biology. Key subfields include Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Molecular Biology, Immunology, and Oncology.

Their work extensively addresses topics such as Pulmonary Hypertension Research and Treatments, Cardiovascular Function and Risk Factors, Chronic Obstructive Pulmonary Disease (COPD) Research, Immune Cells in Cancer, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Heart Failure Treatment and Management, and Epigenetics and DNA Methylation.

Grimminger has multiple publications in leading journals, with frequent appearances in the following venues:

  • American Journal of Respiratory and Critical Care Medicine (11 publications)
  • Cancer Research (5 publications)
  • International Journal of Molecular Sciences (4 publications)
  • Pulmonary Circulation (4 publications)
  • Circulation (3 publications)

Some of the recent papers associated with Grimminger include:

  • Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non-Small Cell Lung Carcinoma, 2020, Cancer Research
  • Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer, 2020, Science Advances
  • Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer, 2020, Journal of Clinical Investigation
  • Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk, 2020, Frontiers in Oncology
  • Severe organising pneumonia following COVID-19, 2020, Thorax

Notable frequent co-authors include Werner Seeger, Hossein Ardeschir Ghofrani, Khodr Tello, Rajkumar Savai, and Ralph T. Schermuly. Collaboration with these scientists has resulted in numerous joint publications contributing to the advancement of pulmonary and cardiovascular medicine as well as cancer research.

Best Publications

  • Sildenafil citrate therapy for pulmonary arterial hypertension.

    Nazzareno Galiè;Hossein A. Ghofrani;Adam Torbicki;Robyn J. Barst

  • Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension

    Hossein-Ardeschir Ghofrani;Andrea M D'Armini;Friedrich Grimminger;Marius M Hoeper

  • Riociguat for the Treatment of Pulmonary Arterial Hypertension

    Hossein-Ardeschir Ghofrani;Nazzareno Galiè;Friedrich Grimminger;Ekkehard Grünig

  • Reversal of experimental pulmonary hypertension by PDGF inhibition.

    Ralph Theo Schermuly;Eva Dony;Hossein Ardeschir Ghofrani;Soni Pullamsetti

  • Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Ralph T Schermuly

  • Real-time quantitative RT–PCR after laser-assisted cell picking

    Ludger Fink;Werner Seeger;Leander Ermert;Jörg Hänze

  • Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy.

    Richard Schulz;Siamak Mahmoudi;Katja Hattar;Ulf Sibelius

  • Inflammation, growth factors, and pulmonary vascular remodeling.

    Paul M. Hassoun;Luc Mouthon;Joan A. Barberà;Saadia Eddahibi

  • Mechanisms of disease: pulmonary arterial hypertension

    Ralph T. Schermuly;Hossein A. Ghofrani;Martin R. Wilkins;Friedrich Grimminger

  • Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension

    Hossein Ardeschir Ghofrani;Ralph Wiedemann;Frank Rose;Horst Olschewski

  • Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

    Hossein A. Ghofrani;Ian H. Osterloh;Friedrich Grimminger

  • Imatinib for the treatment of pulmonary arterial hypertension.

    Hossein A. Ghofrani;Werner Seeger;Friedrich Grimminger

  • Imatinib Mesylate as Add-On Therapy for Pulmonary Arterial Hypertension: Results of the Randomized IMPRES Study

    Marius M. Hoeper;Robyn J. Barst;Robert C. Bourge;Jeremy Feldman

  • Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.

    A Günther;C Siebert;R Schmidt;S Ziegler

  • Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study.

    Konrad Reinhart;Carola Wiegand-Lohnert;Friedrich Grimminger;Martin Kaul

  • Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

    Horst Olschewski;Dieter Walmrath;Ralph Schermuly;H. Ardeshir Ghofrani

  • Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension

    Hossein A Ghofrani;Frank Rose;Ralph T Schermuly;Horst Olschewski

  • Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis

    Horst Olschewski;H. Ardeschir Ghofrani;Dieter Walmrath;Ralph Schermuly

  • Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.

    Dieter Walmrath;Thomas Schneider;Ralph Schermuly;Horst Olschewski

  • Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): 1-Year Results from the CHEST-2 Long-term Extension Study

    Gùrald Simonneau;Andrea D'Armini;Hossein Ghofrani;Friedrich Grimminger

Frequent Co-Authors

Werner Seeger
Werner Seeger University of Giessen
Hossein Ardeschir Ghofrani
Hossein Ardeschir Ghofrani University of Giessen
Ralph T. Schermuly
Ralph T. Schermuly University of Giessen
Norbert Weissmann
Norbert Weissmann University of Giessen
Horst Olschewski
Horst Olschewski Medical University of Graz
Marius M. Hoeper
Marius M. Hoeper Hannover Medical School
Marc Humbert
Marc Humbert University of Paris-Saclay
Walter Klepetko
Walter Klepetko Medical University of Vienna
Gérald Simonneau
Gérald Simonneau University of Paris-Saclay
Lewis J. Rubin
Lewis J. Rubin University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a career in medicine offers a variety of online degree options that can accelerate your professional growth. Specializations such as mental health and healthcare administration are increasingly accessible through flexible study formats, helping students better balance life and work commitments.

For those interested in mental health, online pmhnp programs (Psychiatric Mental Health Nurse Practitioner) provide a fast track to advanced practice roles. Meanwhile, aspiring administrators can compare programs by reviewing the best online mha programs, or focus on affordability with the most affordable mha programs.

For practicing nurses seeking higher credentials, Doctor of Nursing Practice (DNP) degrees are increasingly within reach. The least expensive dnp programs can make advancing your clinical skills and leadership expertise more attainable.

These online pathways not only increase educational access but also help students save on costs and minimize time away from work. Choosing the right program can be a key step towards reshaping your healthcare career.

Best Scientists Citing Friedrich Grimminger

Trending Scientists